Re: Bontzos et al.: Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study (Ophthalmol Retina. 2020;4:1138-1145)
- PMID: 33678431
- DOI: 10.1016/j.oret.2020.11.013
Re: Bontzos et al.: Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study (Ophthalmol Retina. 2020;4:1138-1145)
Comment in
-
Reply.Ophthalmol Retina. 2021 Mar;5(3):e4. doi: 10.1016/j.oret.2020.11.014. Ophthalmol Retina. 2021. PMID: 33678432 No abstract available.
Comment on
-
Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study.Ophthalmol Retina. 2020 Dec;4(12):1138-1145. doi: 10.1016/j.oret.2019.11.004. Epub 2019 Nov 11. Ophthalmol Retina. 2020. PMID: 31937473 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
